Heavy metals have many documented adverse health effects, both acute and chronic, including damage to almost every organ system (e.g., central nervous system, cardiovascular system, gastrointestinal system, excretory system, endocrine system, and skeletal system). In order to safeguard patients who use medical cannabis from these harmful effects, Pennsylvania requires heavy metal concentrations are below specific harmful levels.
US Cannalytics uses industry-leading inductively-coupled plasma mass spectrometry (ICP-MS) instrumentation to measure the concentration of heavy metals down to the parts per billion (ppb) level. Our ISO-accredited methods are also utilized to service the hemp and CBD industries.
US Cannalytics is currently ISO-accredited to test for the following analytes:
Please contact us for custom analyses!